We are a firm specialized in advanced real world evidence (RWE). We contract with biotechnology and pharmaceutical firms to run real world evidence studies for regulatory and reimbursement purposes. Advanced RWE incorporates those studies that make clinical assertions, where data validation and credibility is paramount.
Our team includes industry leaders in secure transfer and use of complete EHR data, clinical natural language processing, healthcare artificial intelligence, and healthcare data policy. We have run studies and defined cohorts for the leading academic medical centers, the National Institutes of Health, and the National Science Foundation. We have testified before Congress in the 21st Century Cures Initiative and helped shape policy in use of advanced clinical data and technologies. We believe that advanced RWE requires a team specialized in the field.
We welcome the opportunity to show you the state of the art, let you work with data in an easy to use graphical interface, and expand the future of medical knowledge together.
Comparison of RCT versus RWE
|Protocol definition||Focused on human subjects protection||Focused on data security and analytic methodology|
|Academic medical center engagement||Clinical division relationships||Bioinformatics division relationships|
|IRB approval||Clinical practices||Security and privacy|
|Patient recruitment||Workflow related||Natural language processing and cohort definition|
|Trial arm distribution||Clinical intervention||Artificial intelligence|
|Validate information||Clinical monitoring||Drill down capabilities and manual annotation|